Menopause

Latest News

Hysterectomy Linked to Long-Term Risk for Depression, Anxiety

Hysterectomy, even with ovarian conservation, is associated with an increased long-term risk for de novo depression.

Discussing Postmenopausal Vulvovaginal Symptoms at a Well-Woman Visit

By

Madeline Morr

Researchers sought to determine patient and visit characteristics associated with the discussion of postmenopausal vulvovaginal symptoms at well-woman examinations.

Inclusion of Additional Clinical Factors Does Not Improve FRAX Performance in Postmenopausal Women

By

Madeline Morr

Researchers sought to assess the ability of the Fracture Risk Assessment Tool to discriminate between women who do and do not experience major osteoporotic fractures.

Vasomotor Symptoms at Menopause Linked to Increased Risk for CVD Events

By

Morgan E. Meissner

Frequent or persistent vasomotor symptoms during the menopause transition are associated with increased risk for later cardiovascular disease events.

Higher Estradiol Dose Improves Metabolic Profile in Early But Not Late Postmenopausal Women

By

Morgan E. Meissner

Higher estradiol doses had significant benefits for cardiovascular risk factors in early postmenopausal women, but these effects were attenuated in late postmenopausal women.

Fezolinetant Reduces Frequency, Severity of Vasomotor Symptoms in Menopause

By

Morgan E. Meissner

The neurokinin 3 receptor antagonist fezolinetant reduces the frequency and severity of vasomotor symptoms in menopause.

Leisure-Time Physical Activity May Attenuate Menopause-Associated Atherogenic Changes

By

Amit Akirov, MD

The menopausal transition may be a stronger determinant of serum cardiovascular risk factors than chronologic age.

FSH Levels Prospectively Identify Women at Risk for Perimenopausal Bone Loss

By

Tyler Rice

Follicle-stimulating hormone levels may independently predict ongoing or imminent bone loss during the menopausal transition.

Effects of Estrogen-Only Treatment in Women With Prior Hysterectomy

By

Amit Akirov, MD

For women aged 50 to 59 years with a history of bilateral oophorectomy, estrogen therapy may have beneficial effects in the long-term.

Effect of Hormone Therapy on Muscle Mass in Postmenopausal Women

By

Amit Akirov, MD

Although use of hormone therapy can have some protective effect on muscle mass in postmenopausal women, the benefit is small in the general population.

Type and Timing of Menopausal Hormone Therapy May Affect Breast Cancer Risk

By

Amit Akirov, MD

Use of menopausal hormonal therapy for 5 years around the start of menopause may be associated with increased risk for breast cancer.